Publication | Closed Access

Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial

Fixed-dose Combination BictegravirTreatment And PreventionWeek 48Antiviral Drug DevelopmentPediatricsAntiviral TherapyPharmacotherapyTenofovir AlafenamideHivAntiviral DrugMedicine